ConductScience.org, home

Paper31316876

Prostate Carcinoma and Pleural Mesothelioma: An Extremely Rare Co-occurrence.

Soni TP and 4 others. Cureus, 2019. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Prostate Carcinoma and Pleural Mesothelioma: An Extremely Rare Co-occurrence. Papers, record 31316876. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31316876

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prostate Carcinoma and Pleural Mesothelioma: An Extremely Rare Co-occurrence.
PubMed
Journal
Cureus
PubMed
Year
2019
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.02
iCite
Revised in PubMed
2020-10-01
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Soni TPTej P
2Soni SSweta
3Somani NNaresh
4Bhattacharya TTaruni
5Kucha NNilesh

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111836664The pathogenesis of mesothelioma.Semin Oncol2002https://conductscience.org/library/papers/11836664PubMed
212212604Multiple primary malignancies in the head and neck: a clinical review of 121 patients.Acta Otolaryngol Suppl2002https://conductscience.org/library/papers/12212604PubMed
312234023Therapy-associated solid tumors.Acta Oncol2002https://conductscience.org/library/papers/12234023PubMed
412630438Incidence of cancer among the participants of the Finnish Asbestos Screening Campaign.Scand J Work Environ Health2003https://conductscience.org/library/papers/12630438PubMed
514966099Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature.J Clin Oncol2004https://conductscience.org/library/papers/14966099PubMed
616878323Cancer incidence after localized therapy for prostate cancer.Cancer2006https://conductscience.org/library/papers/16878323PubMed
718420450Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases.Mutat Res2008https://conductscience.org/library/papers/18420450PubMed
818546265Increased risk of colon cancer after external radiation therapy for prostate cancer.Int J Cancer2008https://conductscience.org/library/papers/18546265PubMed
921733824Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families.Cancer Prev Res (Phila)2011https://conductscience.org/library/papers/21733824PubMed
1022433633Risk of subsequent primary cancer among prostate cancer patients in Bavaria, Germany.Eur J Cancer Prev2012https://conductscience.org/library/papers/22433633PubMed
1122674346Primary cancers before and after prostate cancer diagnosis.Cancer2012https://conductscience.org/library/papers/22674346PubMed
1225224030Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian.Cancer2015https://conductscience.org/library/papers/25224030PubMed
1326139392Gene-asbestos interaction in malignant pleural mesothelioma susceptibility.Carcinogenesis2015https://conductscience.org/library/papers/26139392PubMed
1427260871Risk of second primary cancers after malignant mesothelioma and vice versa.Cancer Lett2016https://conductscience.org/library/papers/27260871PubMed
152923830Incidence of cancer and mortality among employees in the asbestos cement industry in Denmark.Br J Ind Med1989https://conductscience.org/library/papers/2923830PubMed
167353405Presence of asbestos bodies in organs other than the lung.Chest1980https://conductscience.org/library/papers/7353405PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
36980631Second Primary Cancers in a Population-Based Mesothelioma Registry.Cancers (Basel)2023https://conductscience.org/library/papers/36980631

Source PubMed

Download CSV of cited by

Genes14

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31316876

GET https://conductscience.org/api/papers/v1/31316876/authors